Puberty disorders among ART-conceived singletons: a Nordic register study from the CoNARTaS group.


Journal

Human reproduction (Oxford, England)
ISSN: 1460-2350
Titre abrégé: Hum Reprod
Pays: England
ID NLM: 8701199

Informations de publication

Date de publication:
30 09 2022
Historique:
received: 22 03 2022
revised: 10 08 2022
pubmed: 28 8 2022
medline: 5 10 2022
entrez: 27 8 2022
Statut: ppublish

Résumé

Do ART-conceived children have an increased risk for puberty disorders? Both ART-conceived boys and girls had a higher risk of puberty disorders; early puberty was more common among girls and late puberty among boys. Some physiological differences in growth and metabolism have been reported for ART-conceived children compared to non-ART-conceived children. Knowledge on pubertal development and disorders in ART-conceived children is limited. A register-based cohort study was carried out including data from 1985 to 2015. The Committee of Nordic Assisted Reproductive Technology and Safety (CoNARTaS) study population consists of all live and stillborn children, as well as their mothers, registered in the Medical Birth Registers during the study period in Denmark, Sweden, Finland and Norway. A total of 122 321 ART-conceived singletons and 6 576 410 non-ART singletons born in Denmark (1994-2014), Finland (1990-2014), Norway (2002-2015) and Sweden (1985-2015) were included. Puberty disorders were defined using International Classification of Diseases and Related Health Problems (ICD)-9/ICD-10 codes and classified in the following groups: late puberty (6268/E30.0), early puberty (2591 and 2958/E30.1 and E30.8) and unspecified disorders (V212 and V579/E30.9 and Z00.3 as well as Z51.80 for Finland). The results in Cox regression were adjusted for maternal age, parity, smoking, gestational diabetes, chronic hypertension, hypertensive disorders during pregnancy and country, and further for either gestational age, birthweight, small for gestational age or large for gestational age. There were 37 869 children with diagnoses related to puberty disorders, and 603 of them were born after ART. ART-conceived children had higher risks for early (adjusted hazard ratio (aHR) 1.45, 95% CI: 1.29-1.64) and late puberty (aHR 1.47, 95% CI: 1.21-1.77). Girls had more diagnoses related to early puberty (aHR 1.46, 95% CI: 1.29-1.66) and boys with late puberty (aHR 1.55, 95% CI: 1.24-1.95). Using reported puberty disorders with ICD codes in health care registers might vary, which may affect the numbers of cases found in the registers. Register data may give an underestimation both among ART and non-ART-conceived children, especially among non-ART children, who may not be as carefully followed as ART-conceived children. Adjustment for causes and duration of infertility, mothers' own puberty characteristics and BMI, as well as children's BMI, was not possible because data were not available or data were missing for the early years. It was also not possible to compare ART to non-ART siblings or to study the pubertal disorders by cause of subfertility owing to a small number of discordant sibling pairs and a large proportion of missing data on cause of subfertility. This large, register-based study suggests that ART-conceived children have a higher risk for puberty disorders. However, the mechanisms of infertility and pubertal onset are complex, and ART is a rapidly advancing field with various treatment options. Studying the pubertal disorders of ART-conceived offspring is a continuing challenge. This work was supported by the Nordic Trial Alliance: a pilot project jointly funded by the Nordic Council of Ministers and NordForsk (71450), the Central Norway Regional Health Authorities (46045000), the Nordic Federation of Obstetrics and Gynaecology (NF13041, NF15058, NF16026 and NF17043), the Interreg Öresund-Kattegat-Skagerrak European Regional Development Fund (ReproUnion project), the Research Council of Norway's Centre of Excellence funding scheme (262700), the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALFGBG-70940) and FLUX Consortium 'Family Formation in Flux-Causes, Consequences and Possible Futures', funded by the Strategic Research Council, Academy of Finland (DEMOGRAPHY 345130). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors have no conflicts of interest to disclose. N/A.

Identifiants

pubmed: 36029044
pii: 6677190
doi: 10.1093/humrep/deac192
pmc: PMC9527471
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2402-2411

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.

Références

Int J Epidemiol. 2002 Dec;31(6):1235-9
pubmed: 12540728
Arch Gynecol Obstet. 2017 Feb;295(2):285-301
pubmed: 27896474
Hum Reprod. 2020 Sep 1;35(9):2124-2133
pubmed: 32766758
Front Pediatr. 2019 May 08;7:147
pubmed: 31139600
Fertil Steril. 2011 Feb;95(2):528-33
pubmed: 20547390
Andrology. 2018 Sep;6(5):635-653
pubmed: 30296010
Hum Reprod Update. 2013 Mar-Apr;19(2):87-104
pubmed: 23154145
JAMA Pediatr. 2020 Apr 1;174(4):e195881
pubmed: 32040143
Fertil Steril. 2017 Apr;107(4):934-939
pubmed: 28292621
Hum Reprod. 2016 Dec;31(12):2811-2820
pubmed: 27707840
Pediatrics. 2009 May;123(5):e932-9
pubmed: 19403485
J Adolesc. 2019 Feb;71:63-71
pubmed: 30639665
JAMA Pediatr. 2019 Sep 01;173(9):860-865
pubmed: 31329245
Arch Dis Child. 2011 Aug;96(8):740-3
pubmed: 20930013
Hum Reprod Update. 2013 May-Jun;19(3):232-43
pubmed: 23449642
Scand J Public Health. 2019 Dec;47(8):890-898
pubmed: 30328381
PLoS Med. 2021 Jun 25;18(6):e1003683
pubmed: 34170923
Endocr Dev. 2016;29:122-33
pubmed: 26680575
Hum Reprod. 2009 Nov;24(11):2788-95
pubmed: 19648588
Ups J Med Sci. 2020 May;125(2):152-157
pubmed: 32101068
Pediatrics. 2006 Nov;118(5):1819-27
pubmed: 17079550
Hum Reprod. 2012 Jan;27(1):257-64
pubmed: 22081314
Hum Reprod. 2012 Apr;27(4):1156-61
pubmed: 22328555
Eur Child Adolesc Psychiatry. 2020 Aug;29(8):1155-1164
pubmed: 31686240
Hum Reprod. 2019 Apr 1;34(4):724-732
pubmed: 30753468
Curr Opin Obstet Gynecol. 2018 Dec;30(6):361-368
pubmed: 30102607
Obesity (Silver Spring). 2010 May;18(5):1021-5
pubmed: 19851308
Am J Epidemiol. 2019 Jan 1;188(1):47-56
pubmed: 30239589
J Clin Endocrinol Metab. 2010 Jan;95(1):263-70
pubmed: 19926714
Mol Cell Endocrinol. 2010 Aug 5;324(1-2):39-44
pubmed: 20298746
Pediatrics. 2017 Jun;139(6):
pubmed: 28562264
Pediatrics. 2005 Dec;116(6):1323-8
pubmed: 16322154
Int J Epidemiol. 2020 Apr 1;49(2):365-366f
pubmed: 31742613
Pediatrics. 2008 Feb;121 Suppl 3:S167-71
pubmed: 18245510
Hum Reprod. 2020 Apr 28;35(4):968-976
pubmed: 32240284
JAMA Netw Open. 2020 Oct 1;3(10):e2015665
pubmed: 33044548
J Pediatr Endocrinol Metab. 2016 Nov 1;29(11):1229-1231
pubmed: 27771625
Fertil Steril. 2022 May;117(5):1026-1037
pubmed: 35216828
J Clin Endocrinol Metab. 2008 May;93(5):1682-8
pubmed: 18285409
Nicotine Tob Res. 2017 May 01;19(5):539-546
pubmed: 28403467
Reproduction. 2010 Sep;140(3):399-410
pubmed: 20802107
Clin Epidemiol. 2019 Sep 19;11:873-883
pubmed: 31572017
Clin Epidemiol. 2021 Jul 19;13:533-554
pubmed: 34321928
JAMA Netw Open. 2022 Feb 1;5(2):e2146873
pubmed: 35119461
Fertil Steril. 2017 Mar;107(3):622-631.e5
pubmed: 28104241
J Pediatr Adolesc Gynecol. 2016 Dec;29(6):527-530
pubmed: 26703478
Reprod Health. 2019 Jun 14;16(1):82
pubmed: 31200725

Auteurs

R Klemetti (R)

Department of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

B Perry (B)

University of Tampere, Tampere, Finland.

A K Aaris Henningsen (AKA)

The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

A Lærke Spangmose (AL)

The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

A Pinborg (A)

The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

S Opdahl (S)

Department of Public Health and Nursing, The Norwegian University of Science and Technology, Trondheim, Norway.

L Bente Romundstad (LB)

Department of Public Health and Nursing, The Norwegian University of Science and Technology, Trondheim, Norway.

C Bergh (C)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Women's Health, Sahlgrenska University Hospital, Gothenburg, Sweden.

U B Wennerholm (UB)

Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Women's Health, Sahlgrenska University Hospital, Gothenburg, Sweden.

A Tiitinen (A)

Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

M Gissler (M)

Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.
INVEST Joint Research Flagship Centre, University of Turku, Turku, Finland.
Department of Knowledge Brokers, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH